Retireful LLC Makes New Investment in Astera Labs, Inc. $ALAB

Retireful LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 6,214 shares of the company’s stock, valued at approximately $3,001,000. Astera Labs comprises approximately 2.9% of Retireful LLC’s investment portfolio, making the stock its 7th biggest holding.

A number of other large investors have also recently made changes to their positions in ALAB. BlackRock Inc. purchased a new position in Astera Labs in the 2nd quarter worth about $6,609,581,000. Bank of America Corp DE bought a new position in Astera Labs in the 2nd quarter worth about $1,061,791,000. Atreides Management LP grew its stake in Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. Amundi increased its position in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the period. Finally, Artisan Partners Limited Partnership purchased a new position in shares of Astera Labs during the fourth quarter worth approximately $148,980,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 396,745 shares of company stock valued at $155,029,458 over the last 90 days. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Down 2.1%

Shares of NASDAQ:ALAB opened at $274.13 on Thursday. The firm has a 50 day moving average of $334.67 and a 200 day moving average of $252.89. The company has a market capitalization of $47.56 billion, a price-to-earnings ratio of 135.71 and a beta of 3.77. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Ratings Changes

ALAB has been the subject of several research analyst reports. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Royal Bank Of Canada raised their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Morgan Stanley upped their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Finally, Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.